New statins study reignites old row
But data sparks new row among doctors.
X
New statins study reignites old row
https://pharmaphorum.com/news/new-statins-study-reignites-old-row/
statins
Patients may have quit statins after media row
Coverage may have given “disproportional weight” to concerns over side effects.
